Andrew S. Warrilow
Swansea, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens.
Journal: International journal of antimicrobial agents
Published: October 22, 2018
Functional importance for developmental regulation of sterol biosynthesis in Acanthamoeba castellanii.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: March 23, 2018
In Vitro and In Vivo Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection.
Journal: Antimicrobial agents and chemotherapy
Published: September 15, 2017
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
Journal: Antimicrobial agents and chemotherapy
Published: February 20, 2017
In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.
Journal: Antimicrobial agents and chemotherapy
Published: October 24, 2016
Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases.
Journal: Biotechnology for biofuels
Published: July 13, 2016
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Journal: Scientific reports
Published: February 29, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
Journal: Antimicrobial agents and chemotherapy
Published: February 12, 2016
In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.
Journal: Antimicrobial agents and chemotherapy
Published: July 27, 2015
Azole fungicides - understanding resistance mechanisms in agricultural fungal pathogens.
Journal: Pest management science
Published: March 11, 2015
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Journal: Antimicrobial agents and chemotherapy
Published: February 25, 2015
Last Updated: 09/26/2026